Adjuvant radiotherapy after radical prostatectomy provided no meaningful benefit in patients with prostate cancer but increased the risk for urinary ...
A small, nonmechanical, implanted device that continuously releases the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide (Byetta, Bydureon) and designed for ...
The US Food and Drug Administration (FDA) has approved niraparib and abiraterone acetate (Akeega, Janssen Pharmaceuticals) to treat BRCA-positive, metastatic ...
The European Commission has approved bimekizumab (Bimzelx) for the treatment of active psoriatic arthritis (PsA) and active axial spondylarthritis (axSpA) ...
Newly released figures showing a rise in the number of men with advanced prostate cancer have laid bare long-simmering resentment ...
NASHVILLE, Tennessee ― New research shows stark racial and ethnic discrepancies in healthcare outcomes for patients with status epilepticus (SE). ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.